intercell ag
Intercell Completes Japanese Encephalitis Vaccine Ph III Trial In The Philippines
Intercell AG has completed a pivotal Phase III trial in 1,869 children conducted in the Philippines for its IXIARO®/JESPECT® Japanese Encephalitis vaccine.